{"nctId":"NCT01604785","briefTitle":"Low-dose Propofol for Pediatric Migraine","startDateStruct":{"date":"2012-11"},"conditions":["Migraine Headache"],"count":74,"armGroups":[{"label":"Experimental Treatment Group","type":"EXPERIMENTAL","interventionNames":["Drug: Propofol"]},{"label":"Standard Treatment Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Standard Treatment"]}],"interventions":[{"name":"Propofol","otherNames":["Diprivan"]},{"name":"Standard Treatment","otherNames":["NSAIDs / Dopamine Antagonists"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Children 7-18 years of age\n* Acute Migraine Headache\n\nExclusion Criteria:\n\n* Head Trauma\n* CNS infection\n* CNS tumor\n* Previous CNS surgery or device","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Self-Assessed Pain","description":"Percent pain change after initial treatment using 10 point VAS scale","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]}]},{"type":"SECONDARY","title":"Rebound Headache at 24 Hour Follow-up Phone Call","description":"Percentage of subjects reporting recurrence of headache with pain greater than at time of discharge from Emergency Department","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"66.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Emergency Department Length of Stay","description":"Length of stay from administration of medication to Emergency Department discharge in minutes","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"111","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Extrapyramidal Symptoms","Hypoxemia"]}}}